Company intelligence / Profile preview

Microsaic Systems

York, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Microsaic Systems develops and commercializes miniaturised, chip-based mass spectrometry instruments and integrated monitoring solutions used in chemical and biological workflows, including pharmaceutical and environmental/public health applications; it does not develop therapeutic drugs itself but supplies analytical tools that are commercially deployed[1][2][3][5].

Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Network of regional and country-specific distributors and partners for global sales of Microsaic products[1].

Beyond the preview

Go deeper on Microsaic Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microsaic Systems.

Explore the full profile